Investigating how time-restricted eating may prevent pancreatic cancer
Official title: TIME-RESTRICTED FEEDING FOR PANCREATIC CANCER PREVENTION
Funded at University of Tx Md Anderson Can Ctr · NIH-11193654 · Data updated 2026-11-12
This study is looking at how eating only during certain hours of the day might help stop pancreatic cancer in mice, and it aims to find out if this way of eating can change tumor growth and the body's immune system.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | September 20, 2024 |
| Project end | March 19, 2026 |
| Funding year | 2024 |
| Award (this year) | $551,730 |
| NIH project number | 75N91024D00004-0-759102400002-1 |
| Project ID | NIH-11193654 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research would be individuals at high risk for pancreatic cancer, such as those with a family history or genetic predispositions.
✕Less likely to help
Patients who have already been diagnosed with advanced pancreatic cancer may not benefit from this research.
What this research studies
This research explores the effects of time-restricted feeding (TRF) on preventing pancreatic cancer using a mouse model. The study aims to determine how fasting regimens can influence tumor growth, immune responses, and microbiome changes. By conducting both short-term and long-term TRF interventions, researchers hope to identify biomarkers that indicate the effectiveness of this dietary approach in preventing pancreatic intraepithelial neoplasia (PanIN) and pancreatic ductal adenocarcinoma (PDAC).
Why it matters
Potential benefit: If successful, this research could lead to dietary strategies that significantly reduce the risk of developing pancreatic cancer.
How similar studies have gone: Previous research has shown promising results with fasting regimens in cancer prevention, suggesting that this approach may be effective.
Where this research is happening
-
University of Tx Md Anderson Can Ctr
Houston, United States Active
Researchers
- Principal investigator: Vilar Sanchez, Eduardo — University of Tx Md Anderson Can Ctr
- Study coordinator: Vilar Sanchez, Eduardo
Related research
Other NIH-funded projects on the same topics.
-
Microbial Dysbiosis and Its Role in Pancreatic Cancer
A doctor-researcher team at Northwestern University is studying how gut bacteria influence pancreatic cancer and its response to immunotherapy to find new ways to help patients.
-
Targeting aberrant enhancer landscapes in pancreatic cancer
A patient-facing look at a project that aims to understand how pancreatic cancer changes its cell identity and what that means for treatment.
-
Exosome-based microRNA biomarkers for early, non-invasive detection of pancreatic cancer
A study to develop a blood test that uses tiny RNA signals in exosomes to detect pancreatic cancer early, aiming to help people at risk or with early disease.
-
Exosome-based microRNA biomarkers for early detection of pancreatic cancer
A patient-friendly look at a study using tiny blood-based RNA markers inside exosomes to catch pancreatic cancer early without invasive procedures.
-
Programmable implanted living materials to fight pancreatic cancer
A patient-facing program will explore a safe, implantable living material that delivers sequential immunotherapies directly to pancreatic tumors to help fight cancer.
-
Targeting how platelets and pancreatic cancer talk to each other
A study exploring whether blocking the interaction between platelets and pancreatic cancer cells could slow cancer growth and spread and help identify new biomarkers.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.